Novel Coronavirus Pneumonia (COVID-19) convalescence stage
Conditions
Interventions
Sponsors
Tianjin University of TCM
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: 1) Patients who met the diagnostic criteria of covid-19 and discharged after treatment; 2) Aged 18-75 years; 3) Having one or more clinical manifestations of respiratory symptoms or fatigue; 4) Patient informed consent.
Exclusion criteria
Exclusion criteria: 1) Patients who have undergone operations that affect lung function, such as lung transplantation, lung resection, lung volume reduction, etc; 2) Combined with chronic lung diseases that affect lung function, such as severe chronic obstructive pulmonary disease; 3) Patients complicated with diseases affecting cardiac function, such as pulmonary hypertension and heart failure; 4) Accompanied by severe underlying diseases, malignant tumor, severe malnutrition, etc; 5) Resting heart rate > 120/min; 6) Systolic blood pressure > 180mmhg or diastolic blood pressure > 100mmhg; 7) Severe obesity (BMI > 30kg/m2); 8) Allergic constitution, allergic to the drug components involved in the treatment program; 9) Patients who were judged by the investigator to be unable to comply with the study protocol; 10) Pregnant or lactating women.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| cough vas;mMRC;Borg score; | — |
Secondary
| Measure | Time frame |
|---|---|
| TCM syndrom score;PHQ-9 score;GAD-7 score;routine blood test; | — |
Countries
China
Contacts
Public ContactZhang Boli, Zhao Yubin, Dai Erhei
Shijiazhuang Fifth Hospital
Outcome results
None listed